Connection

Marco Cattaneo to Humans

This is a "connection" page, showing publications Marco Cattaneo has written about Humans.
Connection Strength

0.123
  1. Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines. Eur J Intern Med. 2021 07; 89:22-24.
    View in: PubMed
    Score: 0.008
  2. High rates of pulmonary artery occlusions in COVID-19. A meta-analysis. Eur J Clin Invest. 2021 Jan; 51(1):e13433.
    View in: PubMed
    Score: 0.007
  3. Type and dose of heparin in Covid-19: Reply. J Thromb Haemost. 2020 08; 18(8):2063-2064.
    View in: PubMed
    Score: 0.007
  4. Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial. Blood Transfus. 2020 05; 18(3):237-238.
    View in: PubMed
    Score: 0.007
  5. Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified? Thromb Haemost. 2020 08; 120(8):1230-1232.
    View in: PubMed
    Score: 0.007
  6. Severe bleeding and absent ADP-induced platelet aggregation associated with inherited combined CalDAG-GEFI and P2Y12 deficiencies. Haematologica. 2020 07; 105(7):e361-e364.
    View in: PubMed
    Score: 0.007
  7. An "unmodifiable" risk factor that has been modified. Intern Emerg Med. 2021 01; 16(1):157-159.
    View in: PubMed
    Score: 0.007
  8. Aggregometry in the settings of thrombocytopenia, thrombocytosis and antiplatelet therapy. Platelets. 2018 Nov; 29(7):644-649.
    View in: PubMed
    Score: 0.006
  9. Reduced platelet count, but no major platelet function abnormalities, are associated with loss-of-function ATP-binding cassette-1 gene mutations. Clin Sci (Lond). 2017 Aug 15; 131(16):2095-2107.
    View in: PubMed
    Score: 0.006
  10. Effects of pH and concentration of sodium citrate anticoagulant on platelet aggregation measured by light transmission aggregometry induced by adenosine diphosphate. Platelets. 2018 Jan; 29(1):21-26.
    View in: PubMed
    Score: 0.006
  11. von Willebrand factor and its cleaving protease ADAMTS13 balance in coronary artery vessels: Lessons learned from thrombotic thrombocytopenic purpura. A narrative review. Thromb Res. 2017 Jul; 155:78-85.
    View in: PubMed
    Score: 0.006
  12. High on treatment platelet reactivity as a risk factor for adverse left ventricular remodelling after STEMI. Thromb Haemost. 2017 05 03; 117(5):829.
    View in: PubMed
    Score: 0.006
  13. Usefulness of the INNOVANCE PFA P2Y test cartridge for the detection of patients with congenital defects of the platelet P2Y12 receptor for adenosine diphosphate. Thromb Res. 2014 Feb; 133(2):254-6.
    View in: PubMed
    Score: 0.005
  14. Determination of vitamin K1 in plasma by solid phase extraction and HPLC with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Jan 15; 877(3):351-4.
    View in: PubMed
    Score: 0.003
  15. Hyperhomocysteinemia and venous thromboembolism. Semin Thromb Hemost. 2006 Oct; 32(7):716-23.
    View in: PubMed
    Score: 0.003
  16. No effect of fasting plasma total homocysteine on protein C activity in vitro. Blood. 2003 Mar 15; 101(6):2446-7.
    View in: PubMed
    Score: 0.002
  17. Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI). Intern Emerg Med. 2021 Jun; 16(4):1005-1015.
    View in: PubMed
    Score: 0.002
  18. Clinical risk scores for the early prediction of severe outcomes in patients hospitalized for COVID-19. Intern Emerg Med. 2021 06; 16(4):989-996.
    View in: PubMed
    Score: 0.002
  19. The Many Faces of Covid-19 at a Glance: A University Hospital Multidisciplinary Account From Milan, Italy. Front Public Health. 2020; 8:575029.
    View in: PubMed
    Score: 0.002
  20. A case of newly diagnosed immune thrombocytopenia in the COVID-19 era. Intern Emerg Med. 2021 11; 16(8):2221-2225.
    View in: PubMed
    Score: 0.002
  21. Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration. J Thromb Haemost. 2020 11; 18(11):2958-2967.
    View in: PubMed
    Score: 0.002
  22. DOACs and "newer" hemophilia therapies in COVID-19: Reply. J Thromb Haemost. 2020 07; 18(7):1795-1796.
    View in: PubMed
    Score: 0.002
  23. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020 05; 18(5):1023-1026.
    View in: PubMed
    Score: 0.002
  24. Recurrent stent thrombosis in a patient with acute coronary syndrome and ischemic colitis: between life-threatening thrombosis and life-threatening bleeding. Platelets. 2020 Aug 17; 31(6):820-824.
    View in: PubMed
    Score: 0.002
  25. Use of PRECISE-DAPT Score and Admission Platelet Count to Predict Mortality Risk in Patients With Acute Coronary Syndrome. Angiology. 2019 Oct; 70(9):867-877.
    View in: PubMed
    Score: 0.002
  26. Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome. Front Immunol. 2019; 10:773.
    View in: PubMed
    Score: 0.002
  27. [Dual antiplatelet therapy in elderly patients with acute coronary syndrome: does age make the difference?] G Ital Cardiol (Rome). 2018 Jul-Aug; 19(7):420-428.
    View in: PubMed
    Score: 0.002
  28. High on-treatment platelet reactivity and outcome in elderly with non ST-segment elevation acute coronary syndrome - Insight from the GEPRESS study. Int J Cardiol. 2018 05 15; 259:20-25.
    View in: PubMed
    Score: 0.002
  29. Systemic inflammatory status is associated with increased platelet reactivity in the early period after acute coronary syndromes. Platelets. 2018 Jul; 29(5):528-530.
    View in: PubMed
    Score: 0.002
  30. Switching from clopidogrel to prasugrel to protect early invasive treatment in acute coronary syndromes: Results of the switch over trial. Int J Cardiol. 2018 Mar 15; 255:8-14.
    View in: PubMed
    Score: 0.001
  31. Cigarette smoking reduces platelet reactivity independently of clopidogrel treatment in patients with non-ST elevation acute coronary syndromes. Platelets. 2018 May; 29(3):309-311.
    View in: PubMed
    Score: 0.001
  32. Ruxolitinib-associated infections: A systematic review and meta-analysis. Am J Hematol. 2018 03; 93(3):339-347.
    View in: PubMed
    Score: 0.001
  33. Effects of statin therapy on platelet reactivity after percutaneous coronary revascularization in patients with acute coronary syndrome. J Thromb Thrombolysis. 2017 Oct; 44(3):355-361.
    View in: PubMed
    Score: 0.001
  34. Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism. Eur Respir J. 2017 05; 49(5).
    View in: PubMed
    Score: 0.001
  35. Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. Haematologica. 2017 07; 102(7):1192-1203.
    View in: PubMed
    Score: 0.001
  36. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol. 2010 Sep 14; 56(12):919-33.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.